Their drug reduces lipids (fat) in the liver by in
Post# of 148183
(Total Views: 692)
Posted On: 06/26/2021 11:06:57 PM
Re: Goosebumps #94600
Their drug reduces lipids (fat) in the liver by inhibiting the HSD17B13 gene. Lipids will increase inflammation and fibrosis, CCR5 blockade has shown a reduction of lipids and will actively reduce inflammation and the fibrosis that follows.
It's possible that Arrowhead's drug could show positive results in NASH but I think leronlimab would be superior.
It's possible that Arrowhead's drug could show positive results in NASH but I think leronlimab would be superior.
(12)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼